Amanda Atanasio

Regeneron (United States) — United States

Medicine · Health Sciences

7h-index517citations19works4.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Allergic Rhinitis and Sensitization(11), Food Allergy and Anaphylaxis Research(10), Asthma and respiratory diseases(5), Contact Dermatitis and Allergies(4), Mast cells and histamine(3)

Publications19 total

Prediction of symptomatic relief in allergic individuals using a preclinical mouse model of allergic anaphylaxis
Journal of Allergy and Clinical Immunology·2026
Immunological evaluation of cat allergic individuals living with or without a cat
Journal of Allergy and Clinical Immunology·2026
IL4Ra blockade reduces Oral Immunotherapy outcome-related adverse events through inhibition of mast cell activity in a murine model of oral immunotherapy
Journal of Allergy and Clinical Immunology·2026
Utilizing an Indirect Basophil Activation Test to Interrogate the Potency of Bet v 1 and Related Allergens
Journal of Allergy and Clinical Immunology·2026Open Access
Editorial: Allergen-specific antibodies: from basic science to clinical application
Frontiers in Allergy·2025Open Access
A novel mouse model for the study of Alpha-Gal Syndrome
Journal of Allergy and Clinical Immunology·2025
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy
Allergy·2024· 25 citedOpen Access
IgE Sensitization Profiling Unveils Potential Risks of Fatal Asthma
Journal of Allergy and Clinical Immunology·2024Open Access
IL-4R alpha Blockade Reduces the Frequency and Severity of Food-induced Anaphylaxis in a Murine Model of Oral Immunotherapy
Journal of Allergy and Clinical Immunology·2024Open Access
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy
Allergy·2024· 21 citedOpen Access
Production of large, defined genome modifications in rats by targeting rat embryonic stem cells
Stem Cell Reports·2022· 1 citedOpen Access
Biologics as novel therapeutics for the treatment of allergy: Challenges and opportunities
Frontiers in Allergy·2022· 17 citedOpen Access
Efficacy of Anti-Allergen Therapeutics in Preclinical Allergy Model Systems Correlate with Symptomatic Relief in a Clinical Setting
Journal of Allergy and Clinical Immunology·2022
Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a phase 1 study
Journal of Allergy and Clinical Immunology·2021· 71 citedOpen Access
Targeting immunodominant Bet v 1 epitopes with monoclonal antibodies prevents the birch allergic response
Journal of Allergy and Clinical Immunology·2021· 52 citedOpen Access
Targeting birch allergy with monoclonal IgG antibodies that bind allergen and prevent IgE effector cell activation
Journal of Allergy and Clinical Immunology·2020· 1 citedOpen Access
C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice
Scientific Reports·2016· 258 citedOpen Access
Diverse Phenotypes and Specific Transcription Patterns in Twenty Mouse Lines with Ablated LincRNAs
PLoS ONE·2015· 68 citedOpen Access
Generation of fertile and fecund F0 XY female mice from XY ES cells
Transgenic Research·2014· 3 cited

Frequent Co-authors

Jamie Orengo(15), Matthew A. Sleeman(7), Abigail von Recklinghausen(6), André Limnander(6), George D. Yancopoulos(5), Wojtek Auerbach(4), David M. Valenzuela(4), Andrew Murphy(4), William Poueymirou(3), Guochun Gong(3), Ka‐Man Venus Lai(3), Mohamed Kamal(3), Vishal Kamat(3), Meagan P. O’Brien(3), Li‐Hong Ben(3), Derek W. R. White(2), Chia-Jen Siao(2), Susannah Brydges(2), Brian Zambrowicz(2), Claire Q. Wang(2)